Association Between Atrial Fibrillation and Long-term Mortality in Acute MI Patients

Ferdinand Bauke1,2, Christa Meisinger1, Philip Raake2

  • 1Epidemiology, Medical Faculty, University of Augsburg Augsburg, Germany.

PubMed
Abstract

Insights

Atrial fibrillation (AF) significantly increases long-term mortality risk in patients following an acute myocardial infarction (AMI). Aggressive treatment of AF in AMI patients is crucial for reducing mortality.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Public Health

Background:

  • Atrial fibrillation (AF) is a frequent complication of acute myocardial infarction (AMI).
  • Improved therapeutic guidelines and pharmacological options exist for managing AMI and its complications.
  • Contemporary research is needed to clarify AF's impact on long-term mortality post-AMI.

Purpose of the Study:

  • To investigate the effect of atrial fibrillation (AF) on long-term mortality in patients experiencing an incident acute myocardial infarction (AMI).
  • To analyze the association between AF and all-cause and cardiovascular disease mortality after AMI.

Main Methods:

  • A cohort of 2,313 patients (aged 25-84) with incident AMI from 2009-2017 was analyzed.
  • Median follow-up was 4.5 years, with survival and multivariable Cox regression analyses performed.
  • Comparison between patients with AF (n=156) and sinus rhythm (SR, n=2,157) on admission ECG.

Main Results:

  • Patients with AF were older and had more comorbidities, including hypertension and worse kidney function.
  • Long-term all-cause mortality was significantly higher in the AF group (39.1%) compared to the SR group (16.7%).
  • Multivariable analysis revealed a Hazard Ratio (HR) of 1.40 (95% CI [1.05-1.87]; p=0.023) for AF patients versus SR patients.

Conclusions:

  • Atrial fibrillation is an independent risk factor for increased long-term mortality in patients with incident AMI.
  • AF in AMI patients necessitates aggressive management strategies to mitigate mortality risks.
  • Identifying and treating AF promptly in AMI survivors is essential for improving outcomes.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
3
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
2
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
Mitral Regurgitation II: Clinical features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
5